Dr. Joel W Nelson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 15th St N, Saint Cloud, MN 56303 Phone: 320-251-1432 Fax: 320-251-7122 |
Andrea Christine Joplin, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 628 Roosevelt Rd Ste 101, Saint Cloud, MN 56301 Phone: 320-774-3789 Fax: 320-774-3483 |
Dr. Richard William Lucius, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 15th St N, Saint Cloud, MN 56303 Phone: 320-251-1432 Fax: 320-251-7122 |
John Andrew Dvorak, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 109 Doctors Park, Saint Cloud, MN 56303 Phone: 320-253-3637 Fax: 320-253-5412 |
James Evan Heeter, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 109 Doctors Park, Saint Cloud, MN 56303 Phone: 320-253-3637 Fax: 320-253-5412 |
Dr. Steven William Rice, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2055 15th St N, Saint Cloud, MN 56303 Phone: 320-251-1432 Fax: 320-251-7122 |
Mitchell Vincent Gossman, MD Ophthalmology - Neuro-ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 628 Roosevelt Rd Ste 101, Saint Cloud, MN 56301 Phone: 320-774-3789 Fax: 320-774-3483 |
Dr. Bradley Myren Anderson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 15th St N, Saint Cloud, MN 56303 Phone: 320-251-1432 Fax: 320-251-7122 |
Mark Thomas Moberg, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 109 Doctors Park, Saint Cloud, MN 56303 Phone: 320-253-3637 Fax: 320-253-5412 |
News Archive
The National Cancer Institute has awarded $11.5 million to Fred Hutchinson Cancer Research Center to lead a five-year, Seattle-based breast cancer research consortium. The goal of the endeavor is to positively impact breast cancer prevention, detection, treatment and care of women who have or are at risk for the disease.
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd.
Drugs that boost the function of a specific type of neurotransmitter receptor may provide benefit to patients with the second most common type of dementia, according to research by scientists at the University of Alabama at Birmingham published today in the Journal of Neuroscience.
Cells lining the intestinal tract form a critical barrier, protecting our bodies from the billions of bacteria living in the gut. Breaches in this barrier are driven largely by a single signaling molecule called tumor necrosis factor (TNF), elevated amounts of which are associated with inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
› Verified 5 days ago